{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:47:21Z","timestamp":1792176441814,"version":"4.4.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.2275","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T11:53:46Z","timestamp":1586346826000},"page":"e202275","source":"Crossref","is-referenced-by-count":37,"title":["Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome"],"prefix":"10.1001","volume":"3","author":[{"given":"Lori A.","family":"Devlin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis L.","family":"Breeze","sequence":"additional","affiliation":[{"name":"Tufts Clinical and Translational Science Institute, Boston, Massachusetts"},{"name":"Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Terrin","sequence":"additional","affiliation":[{"name":"Tufts Clinical and Translational Science Institute, Boston, Massachusetts"},{"name":"Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Gomez Pomar","sequence":"additional","affiliation":[{"name":"University of Kentucky School of Medicine, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Bada","sequence":"additional","affiliation":[{"name":"University of Kentucky School of Medicine, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta P.","family":"Finnegan","sequence":"additional","affiliation":[{"name":"The College on Problems of Drug Dependence, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"O\u2019Grady","sequence":"additional","affiliation":[{"name":"University of Maryland, College Park"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendr\u00e9e E.","family":"Jones","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Lester","sequence":"additional","affiliation":[{"name":"Women and Infants Hospital, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Tufts Clinical and Translational Science Institute, Boston, Massachusetts"},{"name":"Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"},{"name":"The Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"issue":"2","key":"zoi200119r3","first-page":"37","article-title":"Opioid prescription claims among women of reproductive age: United States, 2008-2012.","volume":"64","author":"Ailes","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"zoi200119r4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","article-title":"Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region: United States, 2006-2015.","volume":"66","author":"O\u2019Donnell","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"zoi200119r5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization: United States, 1999-2014.","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"zoi200119r6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3520","article-title":"Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004-2014.","volume":"141","author":"Winkelman","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"zoi200119r8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG committee opinion No. 524: opioid abuse, dependence, and addiction in pregnancy.","volume":"119","author":"ACOG Committee on Health Care for Underserved Women","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi200119r9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.semperi.2015.12.007","article-title":"Neonatal abstinence syndrome: pharmacologic strategies for the mother and infant.","volume":"40","author":"Kraft","year":"2016","journal-title":"Semin Perinatol"},{"issue":"4","key":"zoi200119r10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1055\/s-0037-1608630","article-title":"A practical approach to neonatal opiate withdrawal syndrome.","volume":"35","author":"Devlin","year":"2018","journal-title":"Am J Perinatol"},{"issue":"7","key":"zoi200119r11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/aje\/kwu190","article-title":"Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.","volume":"180","author":"Brogly","year":"2014","journal-title":"Am J Epidemiol"},{"key":"zoi200119r12","doi-asserted-by":"publisher","first-page":"j3326","DOI":"10.1136\/bmj.j3326","article-title":"Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.","volume":"358","author":"Huybrechts","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"zoi200119r13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.drugalcdep.2012.11.019","article-title":"Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.","volume":"131","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"zoi200119r14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1542\/hpeds.2016-0218","article-title":"Male sex associated with increased risk of neonatal abstinence syndrome.","volume":"7","author":"Charles","year":"2017","journal-title":"Hosp Pediatr"},{"issue":"4","key":"zoi200119r15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","article-title":"Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis.","volume":"172","author":"MacMillan","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"4","key":"zoi200119r16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1089\/bfm.2017.0172","article-title":"Examination of hospital, maternal, and infant characteristics associated with breastfeeding initiation and continuation among opioid-exposed mother-infant dyads.","volume":"13","author":"Schiff","year":"2018","journal-title":"Breastfeed Med"},{"issue":"2","key":"zoi200119r17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.siny.2019.01.002","article-title":"The genetics and epigenetics of neonatal abstinence syndrome.","volume":"24","author":"Wachman","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1-2","key":"zoi200119r18","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management.","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"issue":"1-2","key":"zoi200119r19","first-page":"19","article-title":"Assessment and treatment of abstinence in the infant of the drug-dependent mother.","volume":"12","author":"Finnegan","year":"1975","journal-title":"Int J Clin Pharmacol Biopharm"},{"issue":"6","key":"zoi200119r20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1177\/000992287501400613","article-title":"A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy.","volume":"14","author":"Lipsitz","year":"1975","journal-title":"Clin Pediatr (Phila)"},{"issue":"1-2","key":"zoi200119r21","first-page":"187","article-title":"A study of factors that influence the severity of neonatal narcotic withdrawal.","volume":"2","author":"Ostrea","year":"1975","journal-title":"Addict Dis"},{"issue":"1","key":"zoi200119r22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1940-0640-9-19","article-title":"Review of the assessment and management of neonatal abstinence syndrome.","volume":"9","author":"Bagley","year":"2014","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"zoi200119r23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1542\/hpeds.2012-0079","article-title":"Neonatal abstinence syndrome management from prenatal counseling to postdischarge follow-up care: results of a national survey.","volume":"3","author":"Mehta","year":"2013","journal-title":"Hosp Pediatr"},{"issue":"2","key":"zoi200119r25","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal.","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"issue":"24","key":"zoi200119r26","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi200119r27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/ANC.0000000000000033","article-title":"Validation of the Finnegan Neonatal Abstinence Syndrome Tool\u2013Short Form.","volume":"13","author":"Maguire","year":"2013","journal-title":"Adv Neonatal Care"},{"issue":"1","key":"zoi200119r28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/ANC.0000000000000441","article-title":"A quality improvement initiative to increase scoring consistency and accuracy of the Finnegan Tool: challenges in obtaining reliable assessments of drug withdrawal in neonatal abstinence syndrome.","volume":"18","author":"Timpson","year":"2018","journal-title":"Adv Neonatal Care"},{"issue":"2","key":"zoi200119r30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00004703-199804000-00005","article-title":"The neonatal withdrawal inventory: a simplified score of newborn withdrawal.","volume":"19","author":"Zahorodny","year":"1998","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"zoi200119r31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management.","volume":"5","author":"Jansson","year":"2009","journal-title":"J Opioid Manag"},{"issue":"1","key":"zoi200119r32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5055\/jom.2016.0308","article-title":"Measurement of neonatal abstinence syndrome: evaluation of short forms.","volume":"12","author":"Jones","year":"2016","journal-title":"J Opioid Manag"},{"issue":"9","key":"zoi200119r33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016176","article-title":"Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.","volume":"7","author":"Gomez Pomar","year":"2017","journal-title":"BMJ Open"},{"issue":"8","key":"zoi200119r34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","article-title":"Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial.","volume":"172","author":"Davis","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"5","key":"zoi200119r35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/ajad.v25.5","article-title":"Psychometric assessment of the neonatal abstinence scoring system and the MOTHER NAS Scale.","volume":"25","author":"Jones","year":"2016","journal-title":"Am J Addict"},{"issue":"2","key":"zoi200119r36","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.1542\/peds.2013-4036","article-title":"A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.","volume":"134","author":"Hall","year":"2014","journal-title":"Pediatrics"},{"issue":"1","key":"zoi200119r37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/hpeds.2017-0128","article-title":"A novel approach to assessing infants with neonatal abstinence syndrome.","volume":"8","author":"Grossman","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"8","key":"zoi200119r38","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s41372-018-0109-8","article-title":"Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome.","volume":"38","author":"Wachman","year":"2018","journal-title":"J Perinatol"},{"issue":"6","key":"zoi200119r39","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3360","article-title":"An initiative to improve the quality of care of infants with neonatal abstinence syndrome.","volume":"139","author":"Grossman","year":"2017","journal-title":"Pediatrics"},{"key":"zoi200119r24","first-page":"139","volume-title":"Basic and Therapeutic Aspects of Perinatal Pharmacolology","author":"Finnegan","year":"1975"},{"key":"zoi200119r29","volume-title":"Assessing Signs and Symptoms of Neonatal Abstinence Using the Finnegan Scoring Tool: An Interobserver Reliability Program","author":"D\u2019Apolito","year":"2010"},{"key":"zoi200119r1","unstructured":"Centers for Disease Control and Prevention. Vital signs: prescription painkiller overdoses: a growing epidemic, especially among women. Accessed March 3, 2020. https:\/\/www.cdc.gov\/vitalsigns\/prescriptionpainkilleroverdoses\/"},{"key":"zoi200119r2","unstructured":"International Narcotics Control Board. Report of the International Narcotics Control Board for 2010. Accessed March 3, 2020. https:\/\/www.incb.org\/documents\/Publications\/AnnualReports\/AR2010\/AR_2010_English.pdf"},{"key":"zoi200119r7","unstructured":"U.S. Agency for Healthcare and Quality (AHRQ). Trends in neonatal abstinence syndrome births in the United States. Updated January 18, 2018. Accessed March 3, 2020. https:\/\/www.hcup-us.ahrq.gov\/reports\/Trends_NeonatalAbstinenceSyndrome_Births_UnitedStates.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2764196\/devlin_2020_oi_200119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T11:53:57Z","timestamp":1586346837000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2764196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2275","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]}}}